Blantucas, Norijane .
HRN: 16-65-04 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2025
CEFUROXIME 1.5GM (VIAL)
04/06/2025
04/12/2025
ORAL
500mg
Bid
Cs
Waiting Final Action
04/06/2025
CEFUROXIME 500MG (TAB)
04/06/2025
04/12/2025
PO
500mf
BID
Cs
Waiting Final Action